Respirerx Pharmaceuticals Stock Profit Margin
| RSPIDelisted Stock | USD 0.01 0.00 0.00% |
RespireRx Pharmaceuticals fundamentals help investors to digest information that contributes to RespireRx Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of RespireRx Pink Sheet. The fundamental analysis module provides a way to measure RespireRx Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RespireRx Pharmaceuticals pink sheet.
RespireRx |
RespireRx Pharmaceuticals Company Profit Margin Analysis
RespireRx Pharmaceuticals' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, RespireRx Pharmaceuticals has a Profit Margin of 0.0%. This is 100.0% lower than that of the Pharmaceuticals sector and 100.0% lower than that of the Health Care industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
RespireRx Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RespireRx Pharmaceuticals' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of RespireRx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing RespireRx Pharmaceuticals by comparing valuation metrics of similar companies.RespireRx Pharmaceuticals is currently under evaluation in profit margin category among its peers.
RespireRx Fundamentals
| Return On Asset | -8.34 | ||||
| Current Valuation | 3.18 M | ||||
| Shares Outstanding | 119.59 M | ||||
| Shares Owned By Insiders | 20.63 % | ||||
| Number Of Shares Shorted | 126 | ||||
| Price To Earning | (0.25) X | ||||
| Price To Sales | 1,051 X | ||||
| EBITDA | (2.42 M) | ||||
| Net Income | (3.14 M) | ||||
| Cash And Equivalents | 21 | ||||
| Total Debt | 2.42 M | ||||
| Current Ratio | 0.01 X | ||||
| Book Value Per Share | (0.1) X | ||||
| Cash Flow From Operations | (956.17 K) | ||||
| Short Ratio | 1.47 X | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 0.3 | ||||
| Beta | 0.24 | ||||
| Market Capitalization | 837.16 K | ||||
| Total Asset | 208.74 K | ||||
| Retained Earnings | (156.09 M) | ||||
| Working Capital | (4.89 M) | ||||
| Current Asset | 157 K | ||||
| Current Liabilities | 5.05 M | ||||
| Net Asset | 208.74 K |
About RespireRx Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RespireRx Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RespireRx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RespireRx Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in RespireRx Pink Sheet
If you are still planning to invest in RespireRx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RespireRx Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |